Inflammatory cells orchestrate post-ischemic cardiac remodeling after myocardial infarction (MI). Studies in Kit mutant mice suggest key roles for mast cells in post-ischemic tissue remodeling. However, Kit mutations affect multiple cell types of both immune and non-immune origin. The aim of this study was to address the impact of mast cells on cardiac function following MI, using selectively mast cell-deficient mice (Cpa3
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The number of mast cell progenitor (Lin -CD45 + CD34 + FcγRII/III + β7 + ) increased in the bone marrow and the white adipose tissue on day 3 after MI, infiltrated the heart on day 5 and differentiated to mature mast cells (Cd117 + FcεRI + Sca1 + ) by day 7 in cardiac tissue. To assess the functional effect of mast cell infiltration, the cardiac function 14 days following MI was assessed in wild-type (WT) and 3 mast cells deficient mice models, the kit W/Wv mice, the Cpa3 Cre/+ mice and mice treated with the degranulation inhibitor DSCG (50 μg/g, once a day). There was a significant decrease of g/g, once a day). There was a significant decrease of the left ventricular shortening fraction in all 3 mast cell deficient models compared to WT mice (1.4-, 1.6-and 2-fold respectively) that correlated with increased cardiomyocyte apoptosis in the kit W/Wv mice; and increased fibrosis in the DSCG-treated mice (n=8-14 per group, p<0.01 vs WT). Interestingly, in the Cpa3
Cre/+ mice there were no differences on post-MI cardiac remodeling, but instead we observed a significant reduction in cardiomyocyte contractility (both cell shortening and maximal contracting velocity) with no effect on Ca 2+ transient peak or sarcoplasmic reticulum load.
This work re-evaluates existing mast-cell deficient models on their effect on cardiac remodeling and identifies a novel function for mast cells on modulation of cardiomyocyte contractility, Ca 2+ cycling independently. Identification of the molecular regulators involved in the cardiac effect of mast cell will provide a new platform of regulators with potential therapeutic properties. Bcl11b/CTIP2, a zinc finger transcriptional repressor, interacts with the RNApolymeraseII regulatory complex pTefb and exert an inhibitory action on it. It is also implicated in the regulation of stem cells. Genetic variations in its locus is associated with increased risk for cardiovascular disease making it relevant to study the role of Bcl11b in the heart. Using knockdown/overexpression strategies, we showed that Bcl11b overexpression leads to increased hypertrophic response while its overexpression induces opposite effects. To study its role in vivo, we will use cardiac specific knock out mice and analyse the effect on cardiac remodelling and stem cells. This study will allow us to gain further insights into the molecular mechanisms that control cardiac hypertrophy and cardiac stem cell commitment. 
